848 related articles for article (PubMed ID: 18817572)
21. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F
Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685
[TBL] [Abstract][Full Text] [Related]
22. X-linked myotubular myopathy due to a complex rearrangement involving a duplication of MTM1 exon 10.
Trump N; Cullup T; Verheij JB; Manzur A; Muntoni F; Abbs S; Jungbluth H
Neuromuscul Disord; 2012 May; 22(5):384-8. PubMed ID: 22153990
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
24. [Unilateral presentation of X-linked myotubular myopathy (XLMTM) in two out of three female carriers in a family with no affected male].
Drouet A; Ollagnon-Roman E; Streichenberger N; Biancalana V; Cossée M; Guilloton L; Petiot P
Rev Neurol (Paris); 2008 Feb; 164(2):169-76. PubMed ID: 18358876
[TBL] [Abstract][Full Text] [Related]
25. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
[TBL] [Abstract][Full Text] [Related]
26. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
[TBL] [Abstract][Full Text] [Related]
27. Reducing dynamin 2 (DNM2) rescues
Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy.
Buj-Bello A; Biancalana V; Moutou C; Laporte J; Mandel JL
Hum Mutat; 1999; 14(4):320-5. PubMed ID: 10502779
[TBL] [Abstract][Full Text] [Related]
29. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.
Nicot AS; Toussaint A; Tosch V; Kretz C; Wallgren-Pettersson C; Iwarsson E; Kingston H; Garnier JM; Biancalana V; Oldfors A; Mandel JL; Laporte J
Nat Genet; 2007 Sep; 39(9):1134-9. PubMed ID: 17676042
[TBL] [Abstract][Full Text] [Related]
30. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
[TBL] [Abstract][Full Text] [Related]
31. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
[TBL] [Abstract][Full Text] [Related]
32. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
[TBL] [Abstract][Full Text] [Related]
33. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
[TBL] [Abstract][Full Text] [Related]
34. A rare case of centronuclear myopathy with
Aghbolaghi AG; Lechpammer M
Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838
[TBL] [Abstract][Full Text] [Related]
35. X-linked centronuclear myopathy.
Fan HC; Lee CM; Harn HJ; Cheng SN; Yuh YS
Am J Perinatol; 2003 May; 20(4):173-9. PubMed ID: 12874727
[TBL] [Abstract][Full Text] [Related]
36. Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation.
Jungbluth H; Sewry CA; Buj-Bello A; Kristiansen M; Ørstavik KH; Kelsey A; Manzur AY; Mercuri E; Wallgren-Pettersson C; Muntoni F
Neuromuscul Disord; 2003 Jan; 13(1):55-9. PubMed ID: 12467733
[TBL] [Abstract][Full Text] [Related]
37. X-linked myotubular myopathy in a female infant caused by a new MTM1 gene mutation.
Schara U; Kress W; Tücke J; Mortier W
Neurology; 2003 Apr; 60(8):1363-5. PubMed ID: 12707446
[TBL] [Abstract][Full Text] [Related]
38. The cnm locus, a canine homologue of human autosomal forms of centronuclear myopathy, maps to chromosome 2.
Tiret L; Blot S; Kessler JL; Gaillot H; Breen M; Panthier JJ
Hum Genet; 2003 Sep; 113(4):297-306. PubMed ID: 12884002
[TBL] [Abstract][Full Text] [Related]
39. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
Gómez-Oca R; Cowling BS; Laporte J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808
[TBL] [Abstract][Full Text] [Related]
40. Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands.
Reumers SFI; Erasmus CE; Bouman K; Pennings M; Schouten M; Kusters B; Duijkers FAM; van der Kooi A; Jaeger B; Verschuuren-Bemelmans CC; Faber CG; van Engelen BG; Kamsteeg EJ; Jungbluth H; Voermans NC
Clin Genet; 2021 Dec; 100(6):692-702. PubMed ID: 34463354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
